Today's Low
₹ 1,081.00
Today's High
₹ 1,122.00
52 Weeks Low
₹ 822.90
52 Weeks High
₹ 1,154.00
Lower
₹ 882.70
Upper
₹ 1,324.00
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India. The company offers approximately 450 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, anti-depressant, and anti-coagulant applications, as well as in new chemical entities. It also provides preservatives, such as parabens and parabens formulations for use in cosmetics, animal food, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products to approximately 25 countries worldwide. Ami Organics Limited was founded in 2004 and is based in Surat, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Total Current Assets | 470.1 | 429.6 | 216.2 | 121.0 | 124.1 | 87.2 | 66.5 | 66.2 |
Total Non-Current Assets | 296.9 | 229.3 | 190.8 | 110.9 | 89.1 | 66.5 | 42.3 | 24.9 |
Total Assets | 766.9 | 658.9 | 413.3 | 231.9 | 213.2 | 155.4 | 108.9 | 91.2 |
Total Current Liabilities | 162.9 | 129.3 | 166.0 | 94.6 | 105.6 | 65.0 | 54.8 | 48.6 |
Total Non-Current Liabilities | 10.1 | 7.3 | 80.3 | 25.5 | 25.4 | 32.7 | 15.1 | 15.2 |
Shareholder's Funds | 594.0 | 522.3 | 166.9 | 111.8 | 82.2 | 57.7 | 39.0 | 27.4 |
Total Liabilities | 766.9 | 658.9 | 413.3 | 231.9 | 213.2 | 155.4 | 108.9 | 91.2 |
The Industry Price to BV stands at 6.12, vs the Price to BV of 6.27, which results in a Positive aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.56, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.73, which results in a Negative aspect.
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 1.28, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Total Income | 616.7 | 520.1 | 340.6 | 239.6 | 238.5 | 188.2 | 160.3 | 153.7 |
Total Expenditure | 494.1 | 415.0 | 260.5 | 198.6 | 196.4 | 157.7 | 137.1 | 135.5 |
Operating Profit(Excl OI) | 126.9 | 107.9 | 81.5 | 43.9 | 42.5 | 33.5 | 23.4 | 21.1 |
Add: Other Income | 4.3 | 2.8 | 1.4 | 2.8 | 0.4 | 3.0 | 0.2 | 2.9 |
Operating Profit | 126.9 | 107.9 | 81.5 | 43.9 | 42.5 | 33.5 | 23.4 | 21.1 |
Less: Interest | 2.4 | 6.4 | 5.6 | 5.6 | 4.8 | 3.2 | 3.3 | 2.6 |
PBDT | 124.5 | 101.5 | 75.9 | 38.3 | 37.7 | 30.3 | 20.1 | 18.5 |
Less: Depreciation Amortization | 12.3 | 10.1 | 4.2 | 3.5 | 2.6 | 1.9 | 1.4 | 0.8 |
PBT & Exceptional Items | 112.2 | 91.5 | 71.7 | 34.8 | 35.1 | 28.4 | 18.7 | 17.7 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 112.2 | 91.5 | 71.7 | 34.8 | 35.1 | 28.4 | 18.7 | 17.7 |
Less: Taxation | 28.9 | 19.5 | 17.7 | 7.3 | 11.8 | 9.9 | 6.6 | 5.0 |
Profit After Tax | 83.3 | 72.0 | 54.0 | 27.5 | 23.3 | 18.5 | 12.1 | 12.7 |
Earnings Per Share | 0.2 | 0.2 | 0.1 | 0.9 | 0.7 | 0.6 | 0.4 | 0.4 |
The Industry PAT Growth stands at 32.49, vs the PAT Growth of 17.92, which results in a Negative aspect.
The Industry PE Ratio stands at 42.11, vs the PE Ratio of 97.30, which results in a Positive aspect.
The Industry PAT Margin stands at 9.68, vs the PAT Margin of 11.46, which results in a Positive aspect.
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.27, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Profit Before Tax | 112.2 | 91.5 | 71.7 | 34.8 | 35.1 | 28.3 | 18.7 | 17.7 |
Tax Paid | -24.5 | -22.8 | -14.2 | -8.4 | -13.8 | -7.8 | -6.8 | -3.0 |
Adjustment | 14.1 | 13.6 | 8.0 | 10.2 | 7.5 | 4.4 | 4.1 | 2.7 |
Changes In Working Capital | 112.2 | 91.5 | 71.7 | 34.8 | 35.1 | 28.3 | 18.7 | 17.7 |
Cash Flow after changes in Working Capital | 90.0 | 10.9 | 42.1 | 35.5 | 28.6 | 16.2 | 35.3 | 12.8 |
Cash Flow from Operating Activities | 65.5 | -11.9 | 28.0 | 27.1 | 14.8 | 8.5 | 28.5 | 9.9 |
Cash Flow from Investing Activities | -33.0 | -120.7 | -101.2 | -23.9 | -20.9 | -25.3 | -18.6 | -14.2 |
Cash Flow from Financing Activities | -12.3 | 140.3 | 72.1 | 0.2 | 5.6 | 14.6 | -7.1 | 4.4 |
Net Cash Inflow / Outflow | 20.2 | 7.6 | -1.1 | 3.3 | -0.4 | -2.2 | 2.8 | 0.0 |
Opening Cash & Cash Equivalents | 10.3 | 2.7 | 3.8 | 0.5 | 0.9 | 3.1 | 0.3 | 0.3 |
Closing Cash & Cash Equivalent | 30.5 | 10.3 | 2.7 | 3.8 | 0.5 | 0.9 | 3.1 | 0.3 |
The Industry PCF RATIO stands at 24.36, vs the PCF RATIO of 0.00, which results in a Negative aspect.
The Industry PFCF Ratio stands at 25.03, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1,664.5 | 1,723.6 | 1,423.5 | 1,863.8 | 1,523.6 | 1,469.9 | 1,310.1 | 1,435.4 | 1,411.5 | 1,223.1 |
Total Income | 1,699.4 | 1,738.6 | 1,434.5 | 1,862.1 | 1,553.8 | 1,478.4 | 1,316.3 | 1,437.2 | 1,425.5 | 1,224.7 |
Total Expenditure | 1,399.4 | 1,475.4 | 1,172.0 | 1,455.3 | 1,215.6 | 1,188.6 | 1,080.8 | 1,177.6 | 1,112.3 | 949.4 |
PBIDT (Excl OI) | 265.1 | 248.2 | 251.5 | 408.6 | 308.0 | 281.3 | 229.2 | 257.9 | 299.3 | 273.7 |
Other Income | 34.9 | 15.0 | 11.0 | -1.7 | 30.2 | 8.5 | 6.2 | 1.8 | 13.9 | 1.6 |
Operating Profit | 300.0 | 263.2 | 262.5 | 406.9 | 338.2 | 289.8 | 235.4 | 259.6 | 313.2 | 275.3 |
Interest | 25.4 | 8.2 | 5.1 | 5.9 | 11.9 | 4.5 | 1.8 | 5.9 | 3.4 | 26.9 |
Exceptional Items | 0.0 | -317.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 274.6 | -62.6 | 257.4 | 400.9 | 326.3 | 285.3 | 233.6 | 253.7 | 309.8 | 248.4 |
Depreciation | 37.6 | 36.9 | 34.3 | 34.3 | 30.6 | 28.2 | 30.4 | 31.1 | 24.2 | 23.2 |
Profit Before Tax | 237.0 | -99.4 | 223.2 | 366.6 | 295.7 | 257.1 | 203.2 | 222.6 | 285.6 | 225.2 |
Tax | 58.9 | 70.8 | 56.7 | 94.6 | 72.9 | 66.7 | 54.6 | 9.8 | 90.9 | 50.5 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 178.1 | -170.2 | 166.5 | 272.0 | 222.8 | 190.4 | 148.6 | 212.8 | 194.7 | 174.7 |
Net Profit | 178.1 | -170.2 | 166.5 | 272.0 | 222.8 | 190.4 | 148.6 | 212.8 | 194.7 | 174.7 |
ADDITIONAL INFOS: | ||||||||||
Equity Capital | 368.8 | 368.8 | 364.4 | 364.4 | 364.4 | 364.4 | 364.4 | 364.4 | 364.4 | 364.4 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 4.8 | -4.7 | 4.6 | 7.5 | 6.3 | 5.5 | 4.1 | 6.2 | 5.7 | 5.1 |
Operating Profit Margin | 18.0 | 15.3 | 18.4 | 21.8 | 22.2 | 19.7 | 18.0 | 18.1 | 22.2 | 22.5 |
Net Profit Margin | 10.7 | -9.9 | 11.7 | 14.6 | 14.6 | 13.0 | 11.3 | 14.8 | 13.8 | 14.3 |
The Industry Mcap Growth stands at 19.42, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.00, vs the Net Sales Growth of 0.47, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,175.70 | 1,220.60 | 1,116.25 |
R3 | 1,157.80 | 1,155.20 | 1,104.98 |
R2 | 1,139.90 | 1,138.60 | 1,101.22 |
R1 | 1,116.80 | 1,114.20 | 1,097.46 |
Pivot | 1,098.90 | 1,097.60 | 1,098.90 |
S1 | 1,075.80 | 1,073.20 | 1,089.94 |
S2 | 1,057.90 | 1,056.60 | 1,086.18 |
S3 | 1,034.80 | 1,032.20 | 1,082.43 |
S4 | 1,011.70 | 974.60 | 1,071.15 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
0.00
Bullish
RSI
46.09
Neutral
ROC
-1.90
Bearish
UltimateOscillator
44.00
Neutral
Williams Indicator
-88.72
Bullish
CCI Indicator
-77.30
Neutral
MACD
-2,132.61
Bearish
Stochastic Indicator
14.12
Neutral
ATR
38.37
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
18-09-2023 | 3.00 | 30 | Final |
29-07-2022 | 3.00 | 30 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
12-02-2024 | Quarterly Results |
08-11-2023 | Quarterly Results |
11-08-2023 | Quarterly Results |
04-08-2023 | Preferential Issue of shares |
13-05-2023 | Final Dividend & Audited Results |
22-04-2023 | Inter alia,to consider and evaluate the proposal for: 1. The issue of equity shares and/or other securities of the company by way of preferential issue, subject to the approval of the shareholders through postal ballot process and regulatory approval, as applicable and determination of issue price. 2. Formulation of the Employee Stock Option Plan (?ESOP?) of the Company, in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 subject to approval of the shareholders of the Company through postal ballot process. |
04-02-2023 | Quarterly Results |
05-11-2022 | Quarterly Results |
10-08-2022 | Quarterly Results |
16-05-2022 | Audited Results & Final Dividend |
07-02-2022 | Quarterly Results |
23-10-2021 | Quarterly Results |